Access to capital, government red tape among top barriers cited by biotech firms, survey finds
Though the industry believes the federal government's flagship innovation program, SR&ED, is important and useful, all say it could use some tweaks.
A scientist working at Spartan, a biotech firm located in Ottawa, is pictured in 2017. The biotech industry in Canada is expanding, although investment issues remain, according to a recent survey. The Hill Times photograph by Sam Garcia